Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Evaluating Prognosis and Management Options for Heart Failure: Improving Physician-to-Patient Communication


Release date: October 21, 2016
Expiration date: October 21, 2017
Estimated time to complete activity: 1.0 hour(s)

Faculty
 
Nir Uriel, MD
Professor of Medicine
Medical Director
Advanced Heart Failure, Cardiac Transplantation and Mechanical Circulatory Support
The University of Chicago
Chicago, Illinois
 
Program Overview
 
Heart failure (HF) affects approximately 23 million people worldwide and 5.1 million people in the United States. Generally, HF is described as an inability of the heart to pump enough blood to meet the demands of the body. HF usually presents as limited exercise tolerance, pulmonary and/or splanchnic congestion, and/or peripheral edema due to dyspnea, fatigue, and fluid retention. The signs and symptoms vary with some patients complaining of exercise intolerance and little evidence of fluid retention, while others primarily present with edema, dyspnea, or fatigue. Since no single diagnostic test can be used to diagnose HF, the diagnosis heavily relies on careful history, physical examination, and exclusion of other comorbidities. The goals of HF therapy are clinical improvement of symptoms and ultimately a reduction in the risk of morbidity (including the rate of hospitalization) and mortality. Diagnosis, treatment, and management of HF, however, continue to challenge physicians due to confounding morbidities and polypharmacy, coupled with increasing age. There is currently an urgent need for improved therapies/interventions to not only reduce clinical burden, but also improve HRQOL in patients with HF. In addition, patient-specific and physician-specific barriers to achieve optimal outcomes in HF also need to be addressed.
 
Hospital Medicine Summit (HMS) is an innovative, multi-topic educational initiative designed specifically for hospital-based healthcare providers (hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses). With significant changes occurring in the healthcare system, there is an increased demand on hospital-based healthcare providers to provide care that impacts patients not only in the acute setting, but as they transition back into the community and are managed in the chronic-care healthcare system.
 
Target Audience
 
This educational initiative has been designed for hospital-based healthcare providers, including physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists. 
 
Learning Objectives
 
Upon completion of this educational activity, participants will be able to:
  • Appropriately classify chronic HF per the updated ACCF/AHA guidelines and discuss prognosis with patients
  • Review the latest guidelines for the treatment and management of various patients with chronic HF, including those with comorbidities and polypharmacies
  • Assess the clinical evidence on existing and emerging treatments in chronic HF to provide personalized therapy toward decreasing hospitalizations and mortality
  • Implement strategies to enable patient adherence to treatment to achieve optimal health-related quality of life among patients with chronic HF
Directions to Learner
 
There are no fees for participating and receiving CME/CE credit for this activity. During the period of October 21, 2016 through October 21, 2017, participants must:
  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.
 
Media
 
Internet
 
Accreditation Statement
 
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
 
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
 
Credit Designation
 
Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.100 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number: 0530-9999-16-414-H01-P)
 
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
 
Contact Information
 
For information about the ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or hms@integrityce.com
 
For information about the ACPE or ANCC accreditation of this activity, please contact Global Education Group at (303) 395-1782 or cme@globaleducationgroup.com.
 
Disclosure of Conflicts of Interest
 
Integrity Continuing Education, Inc. and Global Education Group require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education and Global Education Group are committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.
 
The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 
Nir Uriel, MD
Consultant: HeartWare, Novartis, Thoratec
 
The following planners and managers, Andrea Funk, Laura Gilsdorf, Amanda Glazer, PhD, Ashley Marostica, RN, MSN, and Patima Tanapat, PhD, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
 
Disclosure of Unlabeled Use
 
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integrity Continuing Education, Global Education Group, and Novartis do not recommend the use of any agent outside of the labeled indications.
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Global Education Group, and Novartis. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Privacy Policy
 
When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)
 
Minimum System Requirements
 
Windows 98, 2000, XP, 2003, Vista, and 7
Internet Explorer 6/7
Firefox 2
Mozilla 1.7 or higher
Netscape 8.1 or higher
Flash Player 10
Mac OS X 10.3, 10.4
Safari 1.3 (Mac OS 10.3)
Safari 2.0 or higher (Mac OS 10.4)
Firefox 2
Flash Player 10
Use of Internet Explorer browser is not recommended.
Click here for more information on minimum system requirements.
 
Disclaimer
 
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.
 
Provider Statement
 
This CME activity is provided by Integrity Continuing Education.
 
 
This CEU/CNE activity is jointly provided by Global Education Group and Integrity Continuing Education.
 
Supporter Acknowledgement
 
Supported by an educational grant from Novartis.

Fee

$0.00

CE Credits

1.00

Activity Type

  • Knowledge

Target Audience(s)

  • Hospital-based healthcare providers

Accreditation(s)

Accreditation Council for Continuing Medical Ed.
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Support/Credits

 

 

 

 

Activity Number

i664e

Release Date: Oct 21, 2016
Credit Expiration Date: Oct 21, 2017

CE Credits

1.00